ArticleAutism research : official journal of the International Society for Autism Research2025
Screening for Avoidant/Restrictive Food Intake Disorder Symptoms Among Autistic Adults: Measurement Invariance With a Comparison General Sample.
Article in Autism research : official journal of the International Society for Autism Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychometric evaluation of the Persian version of the adult Nine Item ARFID screen (Persian- NIAS).Journal of eating disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Research suggests a higher prevalence of avoidant/restrictive food intake disorder (ARFID) in autistic people across the lifespan compared to the general population. However, ARFID symptoms in autistic people may be misattributed to core autistic traits and gastrointestinal symptoms that often co-occur with autism. This diagnostic overshadowing could lead to the under-recognition and under-treatment of modifiable symptoms of psychopathology in autistic people. Validating ARFID symptom measures in this population is essential to screening for ARFID and tracking treatment outcomes in this population. Multigroup confirmatory factor analysis was used to evaluate the equivalence of the factor structure, factor loadings, and item intercepts of the Nine-Item ARFID Screen (NIAS) between a sample of autistic adults (n = 248) who self-disclosed their diagnosis and a comparison general sample (n = 398). There was support for strong measurement invariance (configural, metric, and scalar) on the NIAS. Autistic adults scored significantly higher on each of the three subscales: selective eating (d = 0.54), appetite impairment (d = 0.27), and fear-driven avoidance of eating (d = 0.37). The NIAS is a valid instrument for measuring ARFID symptomatology in autistic adults. Autistic adults experience elevated symptomatology across all three ARFID eating restrictions. Future research should address whether evidence-based ARFID treatments are efficacious for autistic adults or need to be modified.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.